Several lines of evidence implicate T cells and monocytes/macrophages as important cell types in SSc pathogenesis (2, 3), and modifications in the proportions of CD4+ T cell subpopulations and their functional alterations may contribute to the vascular dysregulation and fibrosis observed in the disease (4, 5). This evidence concerns the gene CD4 and systemic sclerosis.